Trials / Completed
CompletedNCT05982197
Curcumin Gel On Radiation Induced Oral Mucositis
The Effect of Curcuma Long Oral Gel in Relation to Salivary Epidermal Growth Factor & Interleukin-8 on Radiation Induced Oral Mucositis in Iraqi Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Baghdad · Academic / Other
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical study is to investigate the effect of a curcuma longa oral gel (curenext) on reducing radiation-induced oral mucositis severity in cancer patients and provide a context for understanding if there is a relationship between the curcumin clinical effect and production of EGFs and IL8. Researchers will compare between curcumin group and standard treatment group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Curcumin Gel | Curcuma longa oral gel for prevention radiation induced oral mucositis |
| DRUG | Standard Preparation | Standard preparation for prevention radiation induced oral mucositis |
Timeline
- Start date
- 2023-01-03
- Primary completion
- 2023-03-01
- Completion
- 2023-07-02
- First posted
- 2023-08-08
- Last updated
- 2023-08-08
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT05982197. Inclusion in this directory is not an endorsement.